John Patience - 03 Dec 2024 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Dec 2024, 20:48:49 UTC
Prior SEC filing
06 Nov 2024
Next SEC filing
02 Apr 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ David Patience, attorney-in-fact

Key filing fact

John Patience filed Form 4 for Accelerate Diagnostics, Inc (AXDX) on 03 Dec 2024.

Key facts

  • This page summarizes John Patience's Form 4 filing for Accelerate Diagnostics, Inc (AXDX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Dec 2024, 20:48.

Change

  • Previous filing in this sequence was filed on 06 Nov 2024.
  • Current net transaction value: +$314,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AXDX transaction

Common Stock

Purchase

Transaction value
$314,000
Shares
+200,000
Change %
+44%
Price
$1.57
Shares after
653,224
Date
03 Dec 2024
Ownership
By John Patience Living Trust dated 7/23/1993
Footnotes
F1, F2
AXDX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,941
Date
03 Dec 2024
Ownership
By IRA
AXDX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
214,046
Date
03 Dec 2024
Ownership
By Patience Enterprises LP
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents shares purchased by the reporting person from Jack Schuler, a member of the issuer's board of directors, in a private transaction.

Footnote F2

The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the trust.

Footnote F3

The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .